Clinically, WHO classifies coronary heart disease into five types: asymptomatic myocardial ischemia (occult coronary heart disease), angina pectoris, myocardial infarction, ischemic heart failure (ischemic heart disease), and sudden death.
Angina is a clinical syndrome caused by acute, temporary ischemia and hypoxia of the myocardium due to insufficient blood supply to the coronary arteries. Population-based studies show that the incidence of angina increases with age, with the prevalence increasing from 5%-7% in women aged 45-64 years to 10%-12% in women aged 65-84 years, and from 4%-7% in men aged 45-64 years to 12%-14% in men aged 65-84 years.
The rising number of patients with coronary heart disease in China has contributed to the growth of the related drug market.
Nicorandil is an anti-anginal drug that both relieves angina symptoms and improves the prognosis of coronary artery disease, with both nitrate-like effects and ATP-sensitive potassium channel-opening effects. It can both dilate large coronary arteries and diastole coronary microcirculatory resistance vessels, increasing coronary blood flow and myocardial oxygen supply while decreasing myocardial oxygen consumption, which effectively relieve angina pectoris. Several global medication guidelines have made high-level recommendations for Nicorandil.
Nicorandil was developed by Chugai with SIGMART as its trade name. Nicorandil tablets were launched in Japan in 1984 as an anti-anginal drug while the injection was put into clinical use for unstable angina in 1993 and acute heart failure in 2007. Nicorandil from Chugai entered the Chinese market in 2009, and generic drugs from local Chinese companies have been marketed since then. In 2017, Nicorandil became reimbursable under the Chinese medical insurance.
The analyst's survey data shows that from 2017 to 2021, the sales value of nicorandil in the Chinese market kept increasing year by year. Even in the face of COVID-19, the sales value still achieved growth in 2021, reaching CNY618 million (USD92.7 million), with a CAGR of 72.4% from 2017 to 2021. The dosage forms of nicorandil sold in China include tablets and injection, with the latter already occupying the major market share in terms of sales value.
The analyst says that from 2022 to 2031, the number of patients with coronary heart disease and angina will continue to rise in China, and the demand for nicorandil in the Chinese market will keep growing.
Topics Covered:
- The Impact of COVID-19 on China’s Nicorandil Market
- Development Environment of Nicorandil in China
- Sales Volume and value of Nicorandil in China
- Sales Volume and Value of Nicorandil in China by Region
- Major Nicorandil Manufacturers in China and Their Market Share
- Sales Price of Nicorandil in China
- Prospects of China’s Nicorandil Market, 2022-2031
Table of Contents
Companies Mentioned
- Beijing Sihuan Kebao Pharmaceutical Co., Ltd. (RuiKeXi®)
- Chugai Pharmaceutical Co., Ltd. (SIGMART®)
- Xi'an Hanfeng Pharmaceutical Co., Ltd. (XinDiPin®)
- Henan Topfond Pharmaceutical Co., Ltd. (TianFang®)
- Shanxi Xin Yu Pharmaceutical Co., Ltd. (YiWanKang®)
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 50 |
| Published | July 2022 |
| Forecast Period | 2022 - 2031 |
| Estimated Market Value ( CNY | CNY 803 Million |
| Forecasted Market Value ( CNY | CNY 2827 Million |
| Compound Annual Growth Rate | 15.0% |
| Regions Covered | China |
| No. of Companies Mentioned | 5 |
